PerkinElmer Stock Price, News & Analysis (NYSE:PKI)

$78.53 -0.36 (-0.46 %)
(As of 01/17/2018 03:04 PM ET)
Previous Close$78.89
Today's Range$78.17 - $79.75
52-Week Range$50.59 - $79.75
Volume529,700 shs
Average Volume557,430 shs
Market Capitalization$8.74 billion
P/E Ratio35.53
Dividend Yield0.36%
Beta0.77

About PerkinElmer (NYSE:PKI)

PerkinElmer logoPerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets. It provides analytical instrumentation for the industrial market, which includes the chemical, electronics, energy, lubricant, petrochemical and polymer industries. Its products include AAnalyst, Altus, Aquamatic, Avio, AxION, Clarus, DairyGuard, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, Cell carrier and cell::explorer. The Diagnostics segment is focused on reproductive health, emerging market diagnostics and applied genomics. Its products include AutoDELFIA, BACS-on-Beads, Bioo Scientific, BoBs, Datalytix, Dexela, Dexela CMOS FPDs, Evolution, ViaCord, and Zephyr.

Receive PKI News and Ratings via Email

Sign-up to receive the latest news and ratings for PKI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryLife Sciences Tools & Services
SectorHealthcare
SymbolNYSE:PKI
CUSIP71404610
Phone+1-781-6635776

Debt

Debt-to-Equity Ratio0.44%
Current Ratio2.59%
Quick Ratio2.09%

Price-To-Earnings

Trailing P/E Ratio35.5339366515837
Forward P/E Ratio27.27
P/E Growth1.9

Sales & Book Value

Annual Sales$2.12 billion
Price / Sales4.09
Cash Flow$3.53 per share
Price / Cash22.23
Book Value$19.66 per share
Price / Book3.99

Profitability

Trailing EPS$2.21
Net Income$234.29 million
Net Margins18.27%
Return on Equity13.11%
Return on Assets6.82%

Miscellaneous

Employees8,000
Outstanding Shares110,220,000

PerkinElmer (NYSE:PKI) Frequently Asked Questions

What is PerkinElmer's stock symbol?

PerkinElmer trades on the New York Stock Exchange (NYSE) under the ticker symbol "PKI."

How often does PerkinElmer pay dividends? What is the dividend yield for PerkinElmer?

PerkinElmer announced a quarterly dividend on Friday, October 27th. Investors of record on Friday, January 19th will be paid a dividend of $0.07 per share on Friday, February 9th. This represents a $0.28 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date of this dividend is Thursday, January 18th. View PerkinElmer's Dividend History.

How were PerkinElmer's earnings last quarter?

PerkinElmer, Inc. (NYSE:PKI) issued its quarterly earnings data on Thursday, May, 5th. The medical research company reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.51 by $0.05. The medical research company had revenue of $538.70 million for the quarter, compared to analysts' expectations of $532.55 million. PerkinElmer had a return on equity of 13.11% and a net margin of 18.27%. PerkinElmer's revenue was up 2.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.50 earnings per share. View PerkinElmer's Earnings History.

When will PerkinElmer make its next earnings announcement?

PerkinElmer is scheduled to release their next quarterly earnings announcement on Thursday, January, 25th 2018. View Earnings Estimates for PerkinElmer.

Where is PerkinElmer's stock going? Where will PerkinElmer's stock price be in 2018?

15 analysts have issued 1-year price objectives for PerkinElmer's stock. Their predictions range from $55.00 to $81.00. On average, they expect PerkinElmer's share price to reach $71.23 in the next twelve months. View Analyst Ratings for PerkinElmer.

What are Wall Street analysts saying about PerkinElmer stock?

Here are some recent quotes from research analysts about PerkinElmer stock:

  • 1. According to Zacks Investment Research, "PerkinElmer’s share price movement in the last year has been unsatisfactory. However, the company is well poised on solid organic revenue growth. Furthermore, a positive guidance instills our confidence in the stock. PerkinElmer’s strong global foothold is noteworthy, courtesy of its acquisition of Germany-based EUROIMMUN and India-based Tulip Diagnostics. The acquisition of EUROIMMUN should expand PerkinElmer’s reach into autoimmune and allergy diagnostic markets. Management expects the addition to drive R&D expense margin. With an enhanced focus on product innovation, PerkinElmer has considerable potential upside. On the flipside, despite having a solid portfolio, unfavorable foreign exchange is a primary concern. PerkinElmer continues to acquire a large number of companies. While this improves revenue opportunities, it adds to integration risks. Also, high debt levels may hinder the company’s expansion plans." (1/8/2018)
  • 2. Cantor Fitzgerald analysts commented, "Newborn screening in China continues to drive strong diagnostic growth, despite a slight decline in the Haoyuan nucleic acid testing. Diagnostic revenue in China was up more than 20% y/y in 1Q17. Despite a slight moderation in birth rates, uptake of the automated Genetic Screening Processor (GSP) has driven menu expansion. The company reports that 20-25% of the market is now screening for ~20 disorders, while the remaining 80% is screening for 2-4 disorders. India, the largest newborn screening opportunity with an estimated 26M annual births, continues to be relatively unpenetrated, but we do not anticipate a steep adoption ramp as the company experienced in China. Increase in reported revenue guidance leaves organic growth unchanged. The company raised its 2017 revenue guidance to $2.200-2.220B from $2.19-2.20B, implying 4-5% y/y reported revenue growth, compared with our prior estimate of $2.199B. Notably, the 4% organic revenue growth rate is unchanged, and the company expects a slightly lower FX headwind for 2017." (5/5/2017)

Who are some of PerkinElmer's key competitors?

Who are PerkinElmer's key executives?

PerkinElmer's management team includes the folowing people:

  • Robert F. Friel, Chairman of the Board, President, Chief Executive Officer (Age 61)
  • Frank Anders Wilson CPA, Chief Financial Officer, Senior Vice President (Age 58)
  • Deborah Butters, Chief Human Resource Officer, Senior Vice President (Age 47)
  • James L. Corbett, Executive Vice President and President - Discovery & Analytical Solutions (Age 54)
  • Joel S. Goldberg, Senior Vice President - Administration, General Counsel, Secretary (Age 48)
  • Prahlad R. Singh, Senior Vice President and President - Diagnostics (Age 52)
  • Daniel R. Tereau, Senior Vice President, Strategy and Business Development (Age 50)
  • Andrew Okun, Chief Accounting Officer, Vice President (Age 47)
  • Alexis P. Michas, Lead Independent Director (Age 59)
  • Pascale Witz, Director

Who owns PerkinElmer stock?

PerkinElmer's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Bank of Montreal Can (0.05%), First Citizens Bank & Trust Co. (0.02%), Exxonmobil Investment Management Inc. TX (0.02%), Hudson Valley Investment Advisors Inc. ADV (0.01%) and Cutler Group LP (0.00%). Company insiders that own PerkinElmer stock include Alexis P Michas, Andrew Okun, Daniel R Tereau, Frank Anders Wilson, James Corbett, Joel S Goldberg, Kenton J Sicchitano, Nicholas A Lopardo, Patrick J Sullivan, Peter Barrett, Prahlad R Singh, Robert F Friel and Vicki L Sato. View Institutional Ownership Trends for PerkinElmer.

Who sold PerkinElmer stock? Who is selling PerkinElmer stock?

PerkinElmer's stock was sold by a variety of institutional investors in the last quarter, including First Citizens Bank & Trust Co. and Exxonmobil Investment Management Inc. TX. Company insiders that have sold PerkinElmer company stock in the last year include Alexis P Michas, Andrew Okun, Daniel R Tereau, Frank Anders Wilson, Joel S Goldberg, Nicholas A Lopardo, Patrick J Sullivan, Peter Barrett, Prahlad R Singh, Robert F Friel and Vicki L Sato. View Insider Buying and Selling for PerkinElmer.

Who bought PerkinElmer stock? Who is buying PerkinElmer stock?

PerkinElmer's stock was purchased by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Cutler Group LP and Hudson Valley Investment Advisors Inc. ADV. View Insider Buying and Selling for PerkinElmer.

How do I buy PerkinElmer stock?

Shares of PerkinElmer can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is PerkinElmer's stock price today?

One share of PerkinElmer stock can currently be purchased for approximately $79.59.

How big of a company is PerkinElmer?

PerkinElmer has a market capitalization of $8.74 billion and generates $2.12 billion in revenue each year. The medical research company earns $234.29 million in net income (profit) each year or $2.21 on an earnings per share basis. PerkinElmer employs 8,000 workers across the globe.

How can I contact PerkinElmer?

PerkinElmer's mailing address is 940 Winter St, WALTHAM, MA 02451-1457, United States. The medical research company can be reached via phone at +1-781-6635776 or via email at [email protected]


MarketBeat Community Rating for PerkinElmer (PKI)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  295 (Vote Outperform)
Underperform Votes:  311 (Vote Underperform)
Total Votes:  606
MarketBeat's community ratings are surveys of what our community members think about PerkinElmer and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

PerkinElmer (NYSE:PKI) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.272.202.142.07
Ratings Breakdown: 1 Sell Rating(s)
9 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
8 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
8 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
9 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $71.23$68.23$67.25$63.25
Price Target Upside: 6.47% downside3.56% downside4.53% downside8.94% downside

PerkinElmer (NYSE:PKI) Consensus Price Target History

Price Target History for PerkinElmer (NYSE:PKI)

PerkinElmer (NYSE:PKI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/3/2018Evercore ISIInitiated CoverageIn-Line$77.00LowView Rating Details
12/19/2017Bank of AmericaUpgradeUnderperform -> Neutral$78.00LowView Rating Details
11/3/2017Morgan StanleyBoost Price TargetOverweight$77.00 -> $78.00N/AView Rating Details
11/3/2017Robert W. BairdBoost Price TargetOutperform$75.00 -> $78.00N/AView Rating Details
10/20/2017Jefferies GroupReiterated RatingHold$70.00N/AView Rating Details
9/26/2017Goldman Sachs GroupReiterated RatingNeutral -> Neutral$67.00LowView Rating Details
9/26/2017CitigroupReiterated RatingBuy$74.00 -> $80.00LowView Rating Details
9/1/2017CowenReiterated RatingHold$70.00LowView Rating Details
8/4/2017Piper Jaffray CompaniesReiterated RatingBuy$81.00MediumView Rating Details
7/16/2017Cantor FitzgeraldReiterated RatingHoldLowView Rating Details
7/13/2017Wells Fargo & CoInitiated CoverageMarket Perform -> Market Perform$72.00LowView Rating Details
5/6/2017BarclaysSet Price TargetSell$55.00LowView Rating Details
3/27/2017Janney Montgomery ScottUpgradeNeutral -> BuyMediumView Rating Details
2/5/2017BTIG ResearchReiterated RatingHoldN/AView Rating Details
1/18/2017Deutsche BankReiterated RatingHold$55.00N/AView Rating Details
8/5/2016JPMorgan Chase & Co.Boost Price TargetNeutral$52.00 -> $55.00N/AView Rating Details
8/5/2016MizuhoDowngradeBuy -> Neutral$56.00N/AView Rating Details
5/6/2016Stifel NicolausBoost Price TargetBuy$51.00 -> $59.00N/AView Rating Details
(Data available from 1/17/2016 forward)

Earnings

PerkinElmer (NYSE:PKI) Earnings History and Estimates Chart

Earnings by Quarter for PerkinElmer (NYSE:PKI)

PerkinElmer (NYSE PKI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/31/2018N/AView Earnings Details
8/3/2017Q2 2017$0.67$0.67$554.14 million$547.00 millionViewListenView Earnings Details
5/4/2017Q1 2017$0.54$0.55$506.81 million$514.12 millionViewListenView Earnings Details
2/2/2017Q4 2016$0.86$0.83ViewN/AView Earnings Details
11/7/2016Q3$0.66$0.68$572.03 million$548.00 millionViewListenView Earnings Details
8/4/2016Q2 2016$0.66$0.67ViewN/AView Earnings Details
5/5/2016Q116$0.51$0.56$532.55 million$538.70 millionViewN/AView Earnings Details
2/4/2016Q4 2015$0.87$0.86ViewN/AView Earnings Details
11/5/2015Q315$0.60$0.60$554.88 million$563.00 millionViewN/AView Earnings Details
7/30/2015Q2$0.59$0.60$555.66 million$564.00 millionViewListenView Earnings Details
4/30/2015Q115$0.46$0.50$537.27 million$526.90 millionViewN/AView Earnings Details
1/29/2015Q414$0.78$0.85$602.35 million$608.60 millionViewN/AView Earnings Details
10/30/2014Q3$0.57$0.67$550.40 million$542.05 millionViewListenView Earnings Details
8/7/2014Q2$0.59$0.59$572.26 million$556.20 millionViewListenView Earnings Details
4/24/2014Q114$0.44$0.46$531.31 million$531.90 millionViewListenView Earnings Details
1/30/2014Q413$0.70$0.73$588.95 million$594.00 millionViewListenView Earnings Details
10/30/2013Q313$0.48$0.49$523.84 million$524.30 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.48$0.51$532.95 million$543.30 millionViewListenView Earnings Details
4/25/2013Q1 2013$0.48$0.36$532.25 million$505.38 millionViewListenView Earnings Details
1/31/2013Q4 2012$0.65$0.65$577.94 million$577.00 millionViewListenView Earnings Details
10/25/2012$0.44$0.45ViewN/AView Earnings Details
8/2/2012$0.47$0.53ViewN/AView Earnings Details
4/26/2012$0.41$0.43ViewN/AView Earnings Details
2/2/2012$0.51$0.62ViewN/AView Earnings Details
11/3/2011$0.39$0.41ViewN/AView Earnings Details
8/4/2011$0.40$0.42ViewN/AView Earnings Details
5/5/2011$0.31$0.34ViewN/AView Earnings Details
2/3/2011$0.41$0.44ViewN/AView Earnings Details
11/4/2010Q3 2010$0.29$0.31ViewN/AView Earnings Details
8/5/2010Q2 2010$0.33$0.38ViewN/AView Earnings Details
5/6/2010Q1 2010$0.29$0.31ViewN/AView Earnings Details
2/4/2010Q4 2009$0.41$0.43ViewN/AView Earnings Details
10/29/2009Q3 2009$0.27$0.30ViewN/AView Earnings Details
7/30/2009Q2 2009$0.26$0.28ViewN/AView Earnings Details
4/30/2009Q1 2009$0.20$0.26ViewN/AView Earnings Details
1/29/2009Q4 2008$0.42$0.46ViewN/AView Earnings Details
10/23/2008Q3 2008$0.36$0.37ViewN/AView Earnings Details
7/24/2008Q2 2008$0.34$0.35ViewN/AView Earnings Details
4/24/2008Q1 2008$0.25$0.28ViewN/AView Earnings Details
1/24/2008Q4 2007$0.42$0.45ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

PerkinElmer (NYSE:PKI) Earnings Estimates

2018 EPS Consensus Estimate: $3.50
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.80$0.80$0.80
Q2 20181$0.85$0.85$0.85
Q3 20181$0.87$0.87$0.87
Q4 20181$0.98$0.98$0.98
(Earnings estimates data provided by Zacks Investment Research)

Dividends

PerkinElmer (NYSE:PKI) Dividend Information

Next Dividend:2/9/2018
Annual Dividend:$0.28
Dividend Yield:0.36%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:12.67% (Trailing 12 Months of Earnings)
9.72% (Based on This Year's Estimates)
8.51% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for PerkinElmer (NYSE:PKI)

PerkinElmer (NYSE:PKI) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/27/2017quarterly$0.070.39%1/18/20181/19/20182/9/2018
7/24/2017quarterly$0.070.41%10/19/201710/20/201711/10/2017
4/28/2017quarterly$0.070.47%7/19/20177/21/20178/10/2017
1/27/2017quarterly$0.070.54%4/11/20174/14/20175/10/2017
10/26/2016quarterly$0.070.55%1/18/20171/20/20172/10/2017
7/27/2016quarterly$0.070.5%10/12/201610/14/201611/10/2016
4/25/2016quarterly$0.070.55%7/13/20167/15/20168/10/2016
1/28/2016quarterly$0.070.58%4/13/20164/15/20165/10/2016
10/29/2015quarterly$0.070.54%1/13/20161/15/20162/10/2016
7/23/2015quarterly$0.070.55%10/14/201510/16/201511/10/2015
4/27/2015quarterly$0.070.54%7/15/20157/17/20158/10/2015
1/23/2015quarterly$0.070.63%4/15/20154/17/20155/11/2015
10/23/2014quarterly$0.070.67%1/14/20151/16/20152/6/2015
7/24/2014quarterly$0.070.59%10/15/201410/17/201411/7/2014
4/22/2014quarterly$0.070.63%7/16/20147/18/20148/8/2014
1/24/2014quarterly$0.070.68%4/15/20144/18/20145/9/2014
10/24/2013quarterly$0.070.73%1/15/20141/17/20142/7/2014
7/26/2013quarterly$0.070.82%10/16/201310/18/201311/8/2013
6/13/2013quarterly$0.070.85%7/17/20137/19/20138/9/2013
1/25/2013quarterly$0.070.79%4/17/20134/19/20135/10/2013
(Data available from 1/1/2013 forward)

Insider Trades

PerkinElmer (NYSE PKI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.20%
Institutional Ownership Percentage: 91.37%
Insider Trades by Quarter for PerkinElmer (NYSE:PKI)
Institutional Ownership by Quarter for PerkinElmer (NYSE:PKI)

PerkinElmer (NYSE PKI) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/15/2017Andrew OkunInsiderSell12,680$72.00$912,960.0025,121View SEC Filing  
12/7/2017Frank Anders WilsonInsiderSell37,535$70.14$2,632,704.90View SEC Filing  
11/30/2017Alexis P MichasDirectorSell5,000$73.18$365,900.00View SEC Filing  
11/13/2017Peter BarrettDirectorSell7,071$71.07$502,535.9726,271View SEC Filing  
11/7/2017Nicholas A LopardoDirectorSell24,050$70.72$1,700,816.00View SEC Filing  
6/19/2017Andrew OkunInsiderSell4,358$65.00$283,270.0016,799View SEC Filing  
6/1/2017Peter BarrettDirectorSell10,000$63.22$632,200.0029,200View SEC Filing  
5/15/2017Patrick J SullivanDirectorSell6,628$62.59$414,846.5242,951View SEC Filing  
5/4/2017Robert F FrielInsiderSell25,100$60.00$1,506,000.00597,071View SEC Filing  
4/27/2017Robert F FrielInsiderSell124,837$60.11$7,503,952.07696,810View SEC Filing  
3/20/2017Andrew OkunInsiderSell3,000$57.27$171,810.0012,441View SEC Filing  
3/13/2017Joel S GoldbergInsiderSell30,710$55.45$1,702,869.5091,768View SEC Filing  
2/21/2017Alexis P. MichasDirectorSell8,308$55.60$461,924.80View SEC Filing  
2/15/2017Prahlad R SinghInsiderSell9,576$55.00$526,680.0016,319View SEC Filing  
2/9/2017Daniel R TereauInsiderSell5,001$53.16$265,853.1612,147View SEC Filing  
2/9/2017Vicki L SatoDirectorSell8,308$54.01$448,715.0838,278View SEC Filing  
2/6/2017Daniel R TereauInsiderSell4,069$52.01$211,628.699,465View SEC Filing  
12/1/2016Alexis P. MichasDirectorSell15,000$51.00$765,000.00View SEC Filing  
9/22/2016Joel S GoldbergInsiderSell38,095$55.00$2,095,225.0096,299View SEC Filing  
9/12/2016Daniel R TereauInsiderSell18,866$52.00$981,032.0021,241View SEC Filing  
8/24/2016Kenton J SicchitanoDirectorSell15,189$54.87$833,420.4343,160View SEC Filing  
8/17/2016Patrick J SullivanDirectorSell8,308$54.74$454,779.9241,829View SEC Filing  
6/2/2016Alexis P MichasDirectorSell1,953$54.85$107,122.0568,290View SEC Filing  
5/24/2016Robert F FrielCEOSell128,300$55.01$7,057,783.00690,831View SEC Filing  
5/16/2016Robert F FrielCEOSell109,000$55.01$5,996,090.00569,953View SEC Filing  
5/11/2016Robert F FrielCEOSell10,685$55.01$587,781.85573,216View SEC Filing  
5/10/2016Vicki L SatoDirectorSell12,586$54.51$686,062.8636,960View SEC Filing  
5/6/2016Robert F FrielCEOSell4,116$55.00$226,380.00566,647View SEC Filing  
4/18/2016Daniel R TereauInsiderSell2,158$50.79$109,604.828,602View SEC Filing  
3/21/2016James CorbettInsiderSell1,723$48.74$83,979.0228,881View SEC Filing  
2/24/2016Alexis P. MichasDirectorSell10,000$47.56$475,600.00View SEC Filing  
12/3/2015Kenton J SicchitanoDirectorSell10,216$51.05$521,526.8031,658View SEC Filing  
11/3/2015Frank Anders WilsoninsiderSell16,380$52.69$863,062.2055,859View SEC Filing  
10/23/2015Andrew OkunInsiderSell2,000$50.00$100,000.0011,278View SEC Filing  
9/14/2015James CorbettInsiderSell3,000$47.59$142,770.0021,664View SEC Filing  
9/3/2015Kenton J. SicchitanoDirectorSell12,586$47.88$602,617.6841,874View SEC Filing  
6/5/2015Alexis P MichasDirectorSell20,000$52.25$1,045,000.00View SEC Filing  
6/3/2015Frank Anders WilsonInsiderSell16,380$52.60$861,588.00View SEC Filing  
3/27/2015Joel S GoldbergInsiderSell10,646$51.00$542,946.00View SEC Filing  
3/23/2015Andrew OkunInsiderSell2,000$50.09$100,180.00View SEC Filing  
3/20/2015James CorbettInsiderSell5,157$50.23$259,036.11View SEC Filing  
3/18/2015Joel S GoldbergInsiderSell9,000$49.00$441,000.00View SEC Filing  
3/6/2015Patrick J SullivanDirectorSell12,586$46.90$590,283.40View SEC Filing  
3/5/2015Alexis P MichasDirectorSell8,892$47.00$417,924.00View SEC Filing  
3/5/2015Joel S GoldbergInsiderSell9,000$47.00$423,000.00View SEC Filing  
2/10/2015Vicki L SatoDirectorSell24,000$45.55$1,093,200.00View SEC Filing  
2/9/2015Andrew OkunInsiderSell6,262$45.82$286,924.84View SEC Filing  
2/3/2015Nicholas A LopardoDirectorSell8,892$46.30$411,699.60View SEC Filing  
2/3/2015Robert F FrielCEOSell60,709$46.26$2,808,398.34View SEC Filing  
2/2/2015Robert F FrielCEOSell319,065$46.02$14,683,371.30View SEC Filing  
11/14/2014James C MullenDirectorSell8,892$43.73$388,847.16View SEC Filing  
11/13/2014Patrick J SullivanDirectorSell8,892$43.46$386,446.32View SEC Filing  
9/4/2014Kenton J SicchitanoDirectorSell8,892$44.98$399,962.16View SEC Filing  
7/2/2014Daniel R MarshakSVPSell12,000$48.00$576,000.00View SEC Filing  
6/26/2014Daniel R MarshakSVPSell10,000$46.60$466,000.00View SEC Filing  
6/19/2014James CorbettInsiderSell57,126$46.69$2,667,212.94View SEC Filing  
6/9/2014Maurice H TenneyInsiderSell5,504$47.26$260,119.04View SEC Filing  
6/9/2014Robert F FrielCEOSell124,858$46.70$5,830,868.60View SEC Filing  
6/5/2014Alexis P MichasDirectorSell9,146$46.30$423,459.80View SEC Filing  
6/2/2014Alexis P MichasDirectorSell5,854$45.00$263,430.00View SEC Filing  
6/2/2014Joel S GoldbergInsiderSell17,000$45.11$766,870.00View SEC Filing  
5/12/2014Alexis MichasDirectorSell5,000$44.40$222,000.0096,321View SEC Filing  
4/29/2014Nicholas LopardoDirectorSell12,951$41.98$543,682.9878,622View SEC Filing  
4/7/2014James CorbettInsiderSell22,027$45.11$993,637.9721,858View SEC Filing  
3/12/2014Daniel MarshakSVPSell19,292$45.29$873,734.6845,445View SEC Filing  
3/11/2014John LetcherSVPSell41,000$45.40$1,861,400.0034,514View SEC Filing  
3/7/2014Andrew OkunCAOSell9,398$46.35$435,597.3013,816View SEC Filing  
2/27/2014Alexis MichasDirectorSell5,000$45.25$226,250.0095,067View SEC Filing  
2/14/2014Vicki SatoDirectorSell21,843$43.97$960,436.7145,370View SEC Filing  
2/7/2014James MullenDirectorSell12,951$43.73$566,347.2343,178View SEC Filing  
12/13/2013Maurice TenneyInsiderSell25,000$38.91$972,750.0026,109View SEC Filing  
12/10/2013Daniel MarshakSVPSell12,183$39.59$482,324.9742,762View SEC Filing  
11/14/2013Robert FrielCEOSell112,461$37.14$4,176,801.54516,849View SEC Filing  
9/10/2013Robert F FrielCEOSell141,000$37.45$5,280,450.00View SEC Filing  
9/6/2013Andrew OkunCAOSell6,805$36.86$250,832.30View SEC Filing  
5/1/2013Alexis P MichasDirectorSell6,440$30.85$198,674.00View SEC Filing  
4/30/2013James C MullenDirectorSell6,440$30.31$195,196.40View SEC Filing  
4/11/2013Maurice H TenneyInsiderSell9,500$35.00$332,500.00View SEC Filing  
9/13/2012Robert F FrielCEOSell50,565$29.00$1,466,385.00View SEC Filing  
8/9/2012Kenton J SicchitanoDirectorSell9,454$27.93$264,050.22View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

PerkinElmer (NYSE PKI) News Headlines

Source:
DateHeadline
PerkinElmer, Inc. (PKI) Receives Consensus Recommendation of "Hold" from AnalystsPerkinElmer, Inc. (PKI) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - January 16 at 10:32 AM
Zacks Investment Research Upgrades PerkinElmer (PKI) to "Buy"Zacks Investment Research Upgrades PerkinElmer (PKI) to "Buy"
www.americanbankingnews.com - January 8 at 3:26 PM
$615.80 Million in Sales Expected for PerkinElmer, Inc. (PKI) This Quarter$615.80 Million in Sales Expected for PerkinElmer, Inc. (PKI) This Quarter
www.americanbankingnews.com - January 6 at 2:14 AM
PerkinElmer to Hold Earnings Call on Thursday, January 25, 2018PerkinElmer to Hold Earnings Call on Thursday, January 25, 2018
finance.yahoo.com - January 5 at 4:19 PM
$0.94 Earnings Per Share Expected for PerkinElmer, Inc. (PKI) This Quarter$0.94 Earnings Per Share Expected for PerkinElmer, Inc. (PKI) This Quarter
www.americanbankingnews.com - January 4 at 9:44 PM
PerkinElmer (PKI) Now Covered by Evercore ISIPerkinElmer (PKI) Now Covered by Evercore ISI
www.americanbankingnews.com - January 3 at 10:02 PM
Financial Comparison: PerkinElmer (PKI) vs. Accelerate Diagnostics (AXDX)Financial Comparison: PerkinElmer (PKI) vs. Accelerate Diagnostics (AXDX)
www.americanbankingnews.com - December 31 at 11:14 PM
PerkinElmer to Present at J.P. Morgan 36th Annual Healthcare ConferencePerkinElmer to Present at J.P. Morgan 36th Annual Healthcare Conference
finance.yahoo.com - December 27 at 4:59 PM
ETFs with exposure to PerkinElmer, Inc. (United States) : December 25, 2017ETFs with exposure to PerkinElmer, Inc. (United States) : December 25, 2017
finance.yahoo.com - December 25 at 6:09 PM
PerkinElmer (PKI) Closes EUROIMMUN Acquisition for $1.3B - NasdaqPerkinElmer (PKI) Closes EUROIMMUN Acquisition for $1.3B - Nasdaq
www.nasdaq.com - December 23 at 12:31 AM
Bank of America Upgrades PerkinElmer (PKI) to NeutralBank of America Upgrades PerkinElmer (PKI) to Neutral
www.americanbankingnews.com - December 20 at 12:20 AM
PerkinElmer Completes Acquisition of EUROIMMUNPerkinElmer Completes Acquisition of EUROIMMUN
finance.yahoo.com - December 19 at 4:34 PM
$0.94 EPS Expected for PerkinElmer, Inc. (PKI) This Quarter$0.94 EPS Expected for PerkinElmer, Inc. (PKI) This Quarter
www.americanbankingnews.com - December 19 at 9:32 AM
PerkinElmer, Inc. (PKI) Insider Andrew Okun Sells 12,680 SharesPerkinElmer, Inc. (PKI) Insider Andrew Okun Sells 12,680 Shares
www.americanbankingnews.com - December 18 at 5:50 PM
PerkinElmer, Inc. (United States) breached its 50 day moving average in a Bullish Manner : PKI-US : December 18, 2017PerkinElmer, Inc. (United States) breached its 50 day moving average in a Bullish Manner : PKI-US : December 18, 2017
finance.yahoo.com - December 18 at 10:45 AM
ETFs with exposure to PerkinElmer, Inc. (United States) : December 13, 2017ETFs with exposure to PerkinElmer, Inc. (United States) : December 13, 2017
finance.yahoo.com - December 13 at 4:46 PM
PerkinElmer, Inc. (United States) :PKI-US: Earnings Analysis: Q3, 2017 By the Numbers : December 12, 2017PerkinElmer, Inc. (United States) :PKI-US: Earnings Analysis: Q3, 2017 By the Numbers : December 12, 2017
finance.yahoo.com - December 12 at 10:47 AM
Frank Anders Wilson Sells 37,535 Shares of PerkinElmer, Inc. (PKI) StockFrank Anders Wilson Sells 37,535 Shares of PerkinElmer, Inc. (PKI) Stock
www.americanbankingnews.com - December 8 at 5:30 PM
Earnings Momentum Make PerkinElmer (PKI) a Buy - Investorplace.comEarnings Momentum Make PerkinElmer (PKI) a Buy - Investorplace.com
investorplace.com - December 8 at 4:31 PM
Head to Head Comparison: PerkinElmer (PKI) vs. Its PeersHead to Head Comparison: PerkinElmer (PKI) vs. Its Peers
www.americanbankingnews.com - December 8 at 9:28 AM
Head to Head Review: PerkinElmer (PKI) & Its CompetitorsHead to Head Review: PerkinElmer (PKI) & Its Competitors
www.americanbankingnews.com - December 7 at 5:30 PM
Earnings Momentum Make PerkinElmer (PKI) a BuyEarnings Momentum Make PerkinElmer (PKI) a Buy
investorplace.com - December 7 at 12:23 PM
PerkinElmer, Inc. (United States) – Value Analysis (NYSE:PKI) : December 6, 2017PerkinElmer, Inc. (United States) – Value Analysis (NYSE:PKI) : December 6, 2017
finance.yahoo.com - December 6 at 4:36 PM
PerkinElmer, Inc. (United States) breached its 50 day moving average in a Bearish Manner : PKI-US : December 5, 2017PerkinElmer, Inc. (United States) breached its 50 day moving average in a Bearish Manner : PKI-US : December 5, 2017
finance.yahoo.com - December 5 at 12:02 PM
PerkinElmer, Inc. (PKI) Expected to Post Quarterly Sales of $615.80 MillionPerkinElmer, Inc. (PKI) Expected to Post Quarterly Sales of $615.80 Million
www.americanbankingnews.com - December 3 at 6:00 AM
PerkinElmer (PKI) Downgraded by ValuEnginePerkinElmer (PKI) Downgraded by ValuEngine
www.americanbankingnews.com - December 2 at 9:10 PM
PerkinElmer, Inc. (PKI) Director Sells $365,900.00 in StockPerkinElmer, Inc. (PKI) Director Sells $365,900.00 in Stock
www.americanbankingnews.com - December 1 at 9:28 PM
Financial Analysis: PerkinElmer (PKI) versus Its PeersFinancial Analysis: PerkinElmer (PKI) versus Its Peers
www.americanbankingnews.com - December 1 at 9:24 PM
Zacks: Brokerages Expect PerkinElmer, Inc. (PKI) to Announce $0.94 Earnings Per ShareZacks: Brokerages Expect PerkinElmer, Inc. (PKI) to Announce $0.94 Earnings Per Share
www.americanbankingnews.com - December 1 at 2:14 PM
PerkinElmer, Inc. (PKI) Expected to Post Earnings of $0.94 Per SharePerkinElmer, Inc. (PKI) Expected to Post Earnings of $0.94 Per Share
www.americanbankingnews.com - December 1 at 2:14 PM
Earnings Growth Keep PerkinElmer (PKI) a BuyEarnings Growth Keep PerkinElmer (PKI) a Buy
investorplace.com - November 30 at 12:04 PM
Head-To-Head Comparison: PerkinElmer (PKI) versus Its CompetitorsHead-To-Head Comparison: PerkinElmer (PKI) versus Its Competitors
www.americanbankingnews.com - November 29 at 1:14 AM
Comparing PerkinElmer (PKI) & Its CompetitorsComparing PerkinElmer (PKI) & Its Competitors
www.americanbankingnews.com - November 28 at 11:24 PM
PerkinElmer (PKI) and Its Competitors Head to Head SurveyPerkinElmer (PKI) and Its Competitors Head to Head Survey
www.americanbankingnews.com - November 27 at 5:22 PM
PerkinElmer, Inc. (PKI) Given Consensus Rating of "Hold" by AnalystsPerkinElmer, Inc. (PKI) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - November 27 at 2:00 PM
PerkinElmer (PKI) a Buy on Healthy Earnings Growth - Investorplace.comPerkinElmer (PKI) a Buy on Healthy Earnings Growth - Investorplace.com
investorplace.com - November 23 at 5:41 PM
PerkinElmer (PKI) a Buy on Healthy Earnings GrowthPerkinElmer (PKI) a Buy on Healthy Earnings Growth
investorplace.com - November 23 at 12:21 PM
PerkinElmer to Present at Citi Global Healthcare ConferencePerkinElmer to Present at Citi Global Healthcare Conference
finance.yahoo.com - November 22 at 6:42 AM
New Research Coverage Highlights Houghton Mifflin Harcourt, PerkinElmer, Stanley Black & Decker, PVH, BankUnited, and ViewRay — Consolidated Revenues, Company Growth, and Expectations for 2018New Research Coverage Highlights Houghton Mifflin Harcourt, PerkinElmer, Stanley Black & Decker, PVH, BankUnited, and ViewRay — Consolidated Revenues, Company Growth, and Expectations for 2018
finance.yahoo.com - November 21 at 9:21 AM
PerkinElmer’s (PKI) Healthy Quant Score Keep it a BuyPerkinElmer’s (PKI) Healthy Quant Score Keep it a Buy
investorplace.com - November 16 at 12:51 PM
PerkinElmer, Inc. (PKI) Director Sells $502,535.97 in StockPerkinElmer, Inc. (PKI) Director Sells $502,535.97 in Stock
www.americanbankingnews.com - November 14 at 4:32 PM
PerkinElmer, Inc. (PKI) Expected to Announce Quarterly Sales of $616.73 MillionPerkinElmer, Inc. (PKI) Expected to Announce Quarterly Sales of $616.73 Million
www.americanbankingnews.com - November 14 at 4:50 AM
Jefferies Group Weighs in on PerkinElmer, Inc.s FY2017 Earnings (PKI)Jefferies Group Weighs in on PerkinElmer, Inc.'s FY2017 Earnings (PKI)
www.americanbankingnews.com - November 13 at 2:36 AM
Contrasting PerkinElmer (PKI) and Its PeersContrasting PerkinElmer (PKI) and Its Peers
www.americanbankingnews.com - November 12 at 11:54 PM
 Brokerages Expect PerkinElmer, Inc. (PKI) Will Post Earnings of $0.94 Per Share Brokerages Expect PerkinElmer, Inc. (PKI) Will Post Earnings of $0.94 Per Share
www.americanbankingnews.com - November 12 at 7:12 PM
Financial Review: PerkinElmer (PKI) versus Its PeersFinancial Review: PerkinElmer (PKI) versus Its Peers
www.americanbankingnews.com - November 10 at 3:10 AM
Earnings Momentum Keep PerkinElmer (PKI) a BuyEarnings Momentum Keep PerkinElmer (PKI) a Buy
investorplace.com - November 9 at 1:49 PM
Perkinelmer Earns Relative Strength Rating Upgrade; Hits Key ThresholdPerkinelmer Earns Relative Strength Rating Upgrade; Hits Key Threshold
finance.yahoo.com - November 9 at 11:34 AM
PerkinElmer, Inc. (PKI) Director Nicholas A. Lopardo Sells 24,050 SharesPerkinElmer, Inc. (PKI) Director Nicholas A. Lopardo Sells 24,050 Shares
www.americanbankingnews.com - November 8 at 6:32 PM
PerkinElmer, Inc. (PKI) PT Raised to $78.00 at Morgan StanleyPerkinElmer, Inc. (PKI) PT Raised to $78.00 at Morgan Stanley
www.americanbankingnews.com - November 5 at 7:42 AM

SEC Filings

PerkinElmer (NYSE:PKI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

PerkinElmer (NYSE:PKI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

PerkinElmer (NYSE PKI) Stock Chart for Wednesday, January, 17, 2018

Loading chart…

This page was last updated on 1/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.